Qingfeng Lin
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
Papers in
-
- RNA modifications and cancer 4
- RNA Research and Splicing 2
- Circular RNAs in diseases 2
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 2
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Dong Shen (10 shared papers)Weidong Mao (10 shared papers)Feng Lin (2 shared papers)Shaoping Liu (3 shared papers)Xiangdong Lu (1 shared paper)Katrien Wijndaele (1 shared paper)Ulf Ekelund (1 shared paper)Qiong Wang (1 shared paper)
- Journals
- Biomedicine & Pharmacotherapy (3 papers)Oncology Reports (1 paper)Cell Death and Disease (1 paper)Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (1 paper)OncoTargets and Therapy (1 paper)
- Partner nations
- ChinaUnited KingdomNorway
In The Last Decade
Qingfeng Lin
20 papers receiving 374 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 202
- Molecular Biology 197
- Oncology 69
- Physiology 64
- Applied Psychology 10
Countries citing papers authored by Qingfeng Lin
This map shows the geographic impact of Qingfeng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingfeng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingfeng Lin more than expected).
Fields of papers citing papers by Qingfeng Lin
This network shows the impact of papers produced by Qingfeng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingfeng Lin. The network helps show where Qingfeng Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Qingfeng Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 100 | |
| 2 | 2017 | 84 | |
| 3 | 2011 | 67 | |
| 4 | 2009 | 23 | |
| 5 | 2016 | 21 | |
| 6 | 2015 | 18 | |
| 7 | 2016 | 12 | |
| 8 | 2013 | 9 | |
| 9 | 2025 | 9 | |
| 10 | 2018 | 8 | |
| 11 | 2019 | 7 | |
| 12 | 2021 | 4 | |
| 13 | 2017 | 3 | |
| 14 | 2022 | 3 | |
| 15 | 2024 | 2 | |
| 16 | 2013 | 2 | |
| 17 | [Hypophosphatemic osteomalacia and renal Fanconi syndrome induced by adefovir in a patient with chronic hepatitis B]. | 2014 | 2 |
| 18 | 2017 | 1 | |
| 19 | 2022 | 1 | |
| 20 | 2009 | 1 |
About Qingfeng Lin
Qingfeng Lin is a scholar working on Molecular Biology, Cancer Research, Oncology, Pathology and Forensic Medicine and Immunology, having authored 20 papers that have together received 377 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (4 papers), MicroRNA in disease regulation (2 papers), RNA Research and Splicing (2 papers), Circular RNAs in diseases (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper) and Mast cells and histamine (1 paper). The work is most often cited by research in Cancer Research (202 citations), Molecular Biology (197 citations), Oncology (69 citations), Physiology (64 citations) and Applied Psychology (10 citations). Qingfeng Lin has collaborated with scholars based in China, United Kingdom and Norway. Frequent co-authors include Dong Shen, Weidong Mao, Feng Lin, Shaoping Liu, Xiangdong Lu, Katrien Wijndaele, Ulf Ekelund, Qiong Wang, Tao Liu and Jun Su. Their work appears in journals such as Biomedicine & Pharmacotherapy, Oncology Reports, Cell Death and Disease, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics and OncoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.